Trials / Completed
CompletedNCT04728802
Proxalutamide Treatment for Hospitalized COVID-19 Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 645 (actual)
- Sponsor
- Applied Biology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of Proxalutamide as a treatment for hospitalized COVID-19 male and female patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proxalutamide | Proxalutamide 300mg q.d |
| DRUG | Placebo | Placebo pill |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2021-04-15
- Completion
- 2021-04-15
- First posted
- 2021-01-28
- Last updated
- 2021-06-24
- Results posted
- 2021-06-23
Locations
8 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04728802. Inclusion in this directory is not an endorsement.